All News about Ultragenyx Pharmaceutical Inc. - Common Stock
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
December 20, 2024
Via GlobeNewswire
Via Benzinga
Evaluating Ultragenyx Pharmaceutical: Insights From 7 Financial Analysts
November 06, 2024
Via Benzinga
A Look Ahead: Ultragenyx Pharmaceutical's Earnings Forecast
November 04, 2024
Via Benzinga
Decoding 10 Analyst Evaluations For Ultragenyx Pharmaceutical
October 21, 2024
Via Benzinga
Breaking Down Ultragenyx Pharmaceutical: 10 Analysts Share Their Views
September 20, 2024
Via Benzinga
Ultragenyx to Participate in Investor Conferences in December
November 26, 2024
Via GlobeNewswire
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
November 20, 2024
Via GlobeNewswire
Via Benzinga
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
September 18, 2024
Via GlobeNewswire
Ultragenyx to Participate in Investor Conferences in September
August 29, 2024
Via GlobeNewswire
Novartis And Viatris Sued Over Unlawful Use Of HeLa Cells Used For Cancer Treatment Drugs
August 06, 2024
Via Benzinga
Topics
Lawsuit
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.